PHUONG-THUY LE: Open Payments
NPI 1659457315 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 21 payments from 9 companies in 2025. Trend: 2023 $740 · 2024 $1,000 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $213 |
| Janssen Pharmaceuticals, Inc | 3 | $196 |
| Otsuka America Pharmaceutical, Inc. | 2 | $152 |
| Vanda Pharmaceuticals Inc. | 2 | $141 |
| Axsome Therapeutics, Inc. | 2 | $141 |
| E.R. Squibb & Sons, L.L.C. | 2 | $121 |
| Alkermes, Inc. | 2 | $46 |
| Almatica Pharma LLC | 1 | $27 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, INVEGA SUSTENNA, REXULTI, FANAPT, Auvelity, COBENFY, ARISTADA, LOREEV XR.
Industry payments across CA — which companies pay providers there.
